Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000068.xml
Download PDF
Semin intervent Radiol 2008; 25(3): 216-233
DOI: 10.1055/s-0028-1085921
© by Thieme Medical PublishersDOI: 10.1055/s-0028-1085921
Imaging and Percutaneous Treatment of Vascular Anomalies
Further Information
Publication History
Publication Date:
30 September 2008 (online)
ABSTRACT
Vascular anomalies are an extensive group of malformations of the arterial, venous, and lymphatic systems, either in isolation or, more often, in combination. Although mostly congenital, they can occasionally be acquired as well. They present a challenge both for workup and therapy. This article attempts to describe some of their main anomalies, their workup, and their therapies, with the goal of increasing the comfort level of endovascular therapists.
KEYWORDS
Vascular anomalies - malformations - hemangiomas - percutaneous endovascular therapy - embolization
REFERENCES
- 1 Mulliken J B, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982; 69(3) 412-422
- 2 JK W, TS L, CT R et al. For hemangiomas refractory to first line corticosteroid therapy, interferon and vincristine
therapy has been described.
In, International Society for the Study of Vascular Anomalies . Wellington, New Zealand; 2004MissingFormLabel - 3 Chang M W. Updated classification of hemangiomas and other vascular anomalies. Lymphat Res Biol. 2003; 1(4) 259-265
- 4 Upton J, Coombs C J, Mulliken J B, Burrows P E, Pap S. Vascular malformations of the upper limb: a review of 270 patients. J Hand Surg [Am]. 1999; 24(5) 1019-1035
- 5 Cho S K, Do Y S, Shin S W, Kim D I et al.. Arteriovenous malformations of the body and extremities: analysis of therapeutic outcomes and approaches according to a modified angiographic classification. J Endovasc Ther. 2006; 13 527-538
- 6 Jacobowitz G, Rosen R J, Rockman C B et al.. Transcatheter embolization of complex pelvic vascular malformations: results and long-term follow-up. J Vasc Surg. 2001; 33(1) 51-55
- 7 Hadizadeh D R, von Falkenhausen M, Gieseke J et al.. Cerebral arteriovenous malformation: Spetzler-Martin classification at subsecond-temporal-resolution four-dimensional MR angiography compared with that at DSA. Radiology. 2008; 246(1) 205-213
- 8 Bittles M A, Sidhu M K, Sze R W et al.. Multidetector CT angiography of pediatric vascular malformations and hemangiomas: utility of 3-D reformatting in differential diagnosis. Pediatr Radiol. 2005; 35(11) 1100-1106
- 9 Ohgiya Y, Hashimoto T, Gokan T. Dynamic MRI for Distinguishing High-flow from Low-flow peripheral vascular malformations. AJR Am J Roentgenol. 2005; 185(5) 1131-1137
- 10 Lee B B, Do Y S, Yakes W, Kim D I, Mattassi R, Hyon W S. Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg. 2004; 39(3) 590-600
- 11 Do Y S, Yakes W F, Shin S W et al.. ethanol embolization of arteriovenous malformations: interim results. Radiology. 2005; 235(2) 674-682
- 12 Jordan O, Doelker E, Rufenacht D A. Biomaterials used in injectable implants (liquid embolics) for percutaneous filling of vascular spaces. Cardiovasc Intervent Radiol. 2005; 28(5) 561-569
- 13 Osuga K, Hori S, Kitayoshi H et al.. Embolization of high flow arteriovenous malformations: experience with use of superabsorbent polymer microspheres. J Vasc Interv Radiol. 2002; 13(11) 1125-1133
- 14 Yakes W F, Haas D K, Parker S H et al.. Symptomatic vascular malformations: ethanol embolotherapy. Radiology. 1989; 170(3 Pt 2) 1059-1066
- 15 White Jr R I, Pollak J, Persing J et al.. Long-term outcome of embolotherapy and surgery for high-flow extremity arteriovenous malformations. J Vasc Interv Radiol. 2000; 11(10) 1285-1295
- 16 Vikkula M, Boon L, Mulliken J. Molecular genetics of vascular malformations. Matrix Biol. 2001; 20(5–6) 327-335
- 17 Burrows P E, Mason K P. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol. 2004; 15(5) 431-445
- 18 Claudon M, Upton J, Burrows P. Diffuse venous malformations of the upper limb: morphologic characterization by MRI and venography. Pediatr Radiol. 2001; 31(7) 507-514
- 19 Ohlms L A, Forsen J, Burrows P E. Venous malformation of the pediatric airway. Int J Pediatr Otorhinolaryngol. 1996; 37(2) 99-114
- 20 Mason K P, Neufeld E J, Karian V E et al.. Coagulation abnormalities in pediatric and adult patients after sclerotherapy or embolization of vascular anomalies. AJR Am J Roentgenol. 2001; 177(6) 1359-1363
- 21 van Rijswijk C S, van der Linden E, van der Woude H J, van Baalen J M, Bloem J L. Value of dynamic contrast-enhanced MR imaging in diagnosing and classifying peripheral vascular malformations. AJR Am J Roentgenol. 2002; 178(5) 1181-1187
- 22 Dobson M J, Hartley R W, Ashleigh R, Watson Y, Hawnaur J M. MR angiography and MR imaging of symptomatic vascular malformations. Clin Radiol. 1997; 52(8) 595-602
- 23 Kim E Y, Ahn J M, Yoon H K et al.. Intramuscular vascular malformations of an extremity: findings on MR imaging and pathologic correlation. Skeletal Radiol. 1999; 28(9) 515-521
- 24 Herborn C U, Goyen M, Lauenstein T C et al.. Comprehensive time-resolved MRI of peripheral vascular malformations. AJR Am J Roentgenol. 2003; 181(3) 729-735
- 25 Rak K M, Yakes W F, Ray R L et al.. MR imaging of symptomatic peripheral vascular malformations. AJR Am J Roentgenol. 1992; 159(1) 107-112
- 26 Meyer J S, Hoffer F A, Barnes P D, Mulliken J B. Biological classification of soft-tissue vascular anomalies: MR correlation. AJR Am J Roentgenol. 1991; 157(3) 559-564
- 27 Buchta K, Sands J, Rosenkrantz H, Roche W. Early mechanism of action of arterially infused alcohol U.S.P. in renal devitalization. Radiology. 1982; 145(1) 45-48
- 28 Anadon M J, Almendral J, González P et al.. Alcohol concentration determines the type of atrial arrhythmia induced in a porcine model of acute alcoholic intoxication. Pacing Clin Electrophysiol. 1996; 19(11 Pt 2) 1962-1967
- 29 Chi L M, Wu W G. Mechanism of hemolysis of red blood cell mediated by ethanol. Biochim Biophys Acta. 1991; 1062(1) 46-50
- 30 Behnia R. Systemic effects of absolute alcohol embolization in a patient with a congenital arteriovenous malformation of the lower extremity. Anesth Analg. 1995; 80(2) 415-417
- 31 Berenguer B, Burrows P, Zurakowski D, Mulliken J. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg. 1999; 104(1) 1-11 discussion 12-15
- 32 Lee B B, Do Y S, Byun H S et al.. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg. 2003; 37(3) 533-538
- 33 Mitchell S E, Shah A M, Schwengel D. Pulmonary artery pressure changes during ethanol embolization procedures to treat vascular malformations: can cardiovascular collapse be predicted?. J Vasc Interv Radiol. 2006; 17(2 Pt 1) 253-262
- 34 Siniluoto T M, Svendsen P A, Wikholm G M, Fogdestam I, Edström S. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (Sotradecol). Scand J Plast Reconstr Surg Hand Surg. 1997; 31(2) 145-150
- 35 de Lorimier A A. Sclerotherapy for venous malformations. J Pediatr Surg. 1995; 30(2) 188-193 discussion 194
- 36 Cabrera J, Cabrera J J, Garcia-Olmedo M. Sclerosants in microfoam. A new approach in angiology. Int Angiol. 2001; 20(4) 322-329
- 37 Sidhu M K, Perkins J A, Shaw D W, Bittles M A, Andrews R T. Ultrasound-guided endovenous diode laser in the treatment of congenital venous malformations: preliminary experience. J Vasc Interv Radiol. 2005; 16(6) 879-884
- 38 van der Linden E, Overbosch J, Kroft L. Radiofrequency ablation for treatment of symptomatic low-flow vascular malformations after previous unsuccessful therapy. J Vasc Interv Radiol. 2005; 16(5) 747-750
- 39 Belov S. Anatomopathological classification of congenital vascular defects. Semin Vasc Surg. 1993; 6(4) 219-224
- 40 Lee B B, Kim Y W, Seo J M et al.. Current concepts in lymphatic malformation. Vasc Endovascular Surg. 2005; 39(1) 67-81
- 41 Mulliken J B, Fishman S J, Burrows P E. Vascular anomalies. Curr Probl Surg. 2000; 37(8) 517-584
- 42 Alomari A I, Karian V E, Lord D J, Padua H M, Burrows P E. Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J Vasc Interv Radiol. 2006; 17(10) 1639-1648
- 43 Sanlialp I, Karnak I, Tanyel F, Senocak M, Büyükpamukçu N. Sclerotherapy for lymphangioma in children. Int J Pediatr Otorhinolaryngol. 2003; 67(7) 795-800
- 44 Dubois J, Garel L, Abela A, Laberge L, Yazbeck S. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology. 1997; 204(3) 651-654
- 45 Ogita S, Tsuto T, Deguchi E et al.. OK-432 therapy for unresectable lymphangiomas in children. J Pediatr Surg. 1991; 26(3) 263-268 discussion 268-270
- 46 Laranne J, Keski-Nisula L, Rautio R, Rautiainen M, Airaksinen M. OK-432 (Picibanil) therapy for lymphangiomas in children. Eur Arch Otorhinolaryngol. 2002; 259(5) 274-278
- 47 Molitch H I, Unger E C, Witte C L, vanSonnenberg E. Percutaneous sclerotherapy of lymphangiomas. Radiology. 1995; 194(2) 343-347
- 48 Orford J, Barker A, Thonell S, King P, Murphy J. Bleomycin therapy for cystic hygroma. J Pediatr Surg. 1995; 30(9) 1282-1287
- 49 Shiels 2nd W E, Kenney B, Caniano D, Besner G. Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. J Pediatr Surg. 2008; 43(1) 136-139 discussion 140
- 50 Burrows P E, Laor T, Paltiel H, Robertson R L. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin. 1998; 16(3) 455-488
- 51 Fishman S J, Mulliken J B. Hemangiomas and vascular malformations of infancy and childhood. Pediatr Clin North Am. 1993; 40(6) 1177-1200
- 52 Haggstrom A N, Drolet B A Hemangioma Investigator Group et al.. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr. 2007; 150(3) 291-294
- 53 Frieden I J, Haggstrom A N, Drolet B A et al.. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7–9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol. 2005; 22(5) 383-406
- 54 Haggstrom A N, Drolet B A, Baselga E et al.. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics. 2006; 118(3) 882-887
- 55 Ezekowitz R A, Mulliken J B, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992; 326(22) 1456-1463
- 56 Fishman S J, Burrows P E, Leichtner A M, Mulliken J B. Gastrointestinal manifestations of vascular anomalies in childhood: varied etiologies require multiple therapeutic modalities. J Pediatr Surg. 1998; 33(7) 1163-1167
- 57 Achauer B M, Chang C J, Vander Kam V M. Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg. 1997; 99(5) 1301-1308
- 58 Laor T, Jaramillo D, Hoffer F, Kasser J. MR imaging in congenital lower limb deformities. Pediatr Radiol. 1996; 26(6) 381-387
- 59 Enjolras O, Wassef M, Mazoyer E et al.. Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas. J Pediatr. 1997; 130(4) 631-640
- 60 Berenguer B, Mulliken J, Enjolras O et al.. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol. 2003; 6(6) 495-510
- 61 Enjolras O, Mulliken J, Boon L et al.. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg. 2001; 107(7) 1647-1654
- 62 Donnelly L F, Adams D M, Bisset G S. Vascular malformations and hemangiomas: a practical approach in a multidisciplinary clinic. AJR Am J Roentgenol. 2000; 174(3) 597-608
- 63 Dubois J, Patriquin H, Garel L et al.. Soft-tissue hemangiomas in infants and children: diagnosis using Doppler sonography. AJR Am J Roentgenol. 1998; 171(1) 247-252
- 64 Hovius S E, Borg D H, Paans P R, Pieterman H. The diagnostic value of magnetic resonance imaging in combination with angiography in patients with vascular malformations: a prospective study. Ann Plast Surg. 1996; 37(3) 278-285
- 65 Kern S, Niemeyer C, Darge K et al.. Differentiation of vascular birthmarks by MR imaging. An investigation of hemangiomas, venous and lymphatic malformations. Acta Radiol. 2000; 41(5) 453-457
- 66 Konez O, Burrows P, Mulliken J, Fishman S, Kozakewich H. Angiographic features of rapidly involuting congenital hemangioma (RICH). Pediatr Radiol. 2003; 33(1) 15-19
- 67 Laor T, Burrows P. Congenital anomalies and vascular birthmarks of the lower extremities. Magn Reson Imaging Clin N Am. 1998; 6(3) 497-519
- 68 Chamlin S, Haggstrom A, Drolet B et al.. Multicenter prospective study of ulcerated hemangiomas. J Pediatr. 2007; 151(6) 684-689
- 69 Amir J, Metzker A, Krikler R, Reisner S. Strawberry hemangioma in preterm infants. Pediatr Dermatol. 1986; 3(4) 331-332
- 70 Jacobs A H, Walton R G. The incidence of birthmarks in the neonate. Pediatrics. 1976; 58(2) 218-222
- 71 Boye E, Yu Y, Paranya G et al.. Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest. 2001; 107(6) 745-752
- 72 Walter J W, North P E, Waner M et al.. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chromosomes Cancer. 2002; 33(3) 295-303
- 73 North P E, Waner M, Mizeracki A, Mihm M C. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000; 31(1) 11-22
- 74 North P E, Waner M, Mizeracki A et al.. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol. 2001; 137(5) 559-570
- 75 Yu Y, Flint A, Mulliken J, Wu J, Bischoff J. Endothelial progenitor cells in infantile hemangioma. Blood. 2004; 103(4) 1373-1375
- 76 Dubois J, Milot J, Jaeger B et al.. Orbit and eyelid hemangiomas: is there a relationship between location and ocular problems?. J Am Acad Dermatol. 2006; 55(4) 614-619
- 77 Haik B G, Jakobiec F A, Ellsworth R M, Jones I S. Capillary hemangioma of the lids and orbit: an analysis of the clinical features and therapeutic results in 101 cases. Ophthalmology. 1979; 86(5) 760-792
- 78 Stigmar G, Crawford J, Ward C, Thomson H. Ophthalmic sequelae of infantile hemangiomas of the eyelids and orbit. Am J Ophthalmol. 1978; 85(6) 806-813
- 79 Enjolras O, Riche M, Merland J, Escande J. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics. 1990; 85(4) 491-498
- 80 Rahbar R, Nicollas R, Roger G et al.. The biology and management of subglottic hemangioma: past, present, future. Laryngoscope. 2004; 114(11) 1880-1891
- 81 Bitar M A, Moukarbel R V, Zalzal G H. Management of congenital subglottic hemangioma: trends and success over the past 17 years. Otolaryngol Head Neck Surg. 2005; 132(2) 226-231
- 82 Christison-Lagay E R, Burrows P E, Alomari A et al.. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg. 2007; 42(1) 62-67 discussion 67-68
- 83 Burrows P E, Dubois J, Kassarjian A. Pediatric hepatic vascular anomalies. Pediatr Radiol. 2001; 31(8) 533-545
- 84 Boon L M, Burrows P E, Paltiel H J et al.. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr. 1996; 129(3) 346-354
- 85 Kassarjian A, Dubois J, Burrows P E. Angiographic classification of hepatic hemangiomas in infants. Radiology. 2002; 222(3) 693-698
- 86 Kassarjian A, Zurakowski D, Dubois J et al.. Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. AJR Am J Roentgenol. 2004; 182(3) 785-795
- 87 Albright A L, Gartner J C, Wiener E S. Lumbar cutaneous hemangiomas as indicators of tethered spinal cords. Pediatrics. 1989; 83(6) 977-980
- 88 Burke D R, Verstandig A, Edwards O et al.. Infantile hemangioendothelioma: angiographic features and factors determining efficacy of hepatic artery embolization. Cardiovasc Intervent Radiol. 1986; 9(3) 154-157
- 89 Fishman S J, Mulliken J B. Vascular anomalies. A primer for pediatricians. Pediatr Clin North Am. 1998; 45(6) 1455-1477
- 90 Pope E, Krafchik B, Macarthur C et al.. Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial. Pediatrics. 2007; 119(6) e1239-e1247
- 91 Al-Sebeih K, Manoukian J. Systemic steroids for the management of obstructive subglottic hemangioma. J Otolaryngol. 2000; 29(6) 361-366
- 92 Sadan N, Wolach B. Treatment of hemangiomas of infants with high doses of prednisone. J Pediatr. 1996; 128(1) 141-146
- 93 Boon L M, MacDonald D M, Mulliken J B. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg. 1999; 104(6) 1616-1623
- 94 George M E, Sharma V, Jacobson J, Simon S, Nopper A J. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol. 2004; 140(8) 963-969
- 95 Kushner B J. The treatment of periorbital infantile hemangioma with intralesional corticosteroid. Plast Reconstr Surg. 1985; 76(4) 517-526
- 96 Sloan G M, Reinisch J F, Nichter L S et al.. Intralesional corticosteroid therapy for infantile hemangiomas. Plast Reconstr Surg. 1989; 83(3) 459-467
- 97 Greinwald J H, Burke D K, Bonthius D J, Bauman N M, Smith R J. An update on the treatment of hemangiomas in children with interferon alfa-2a. Arch Otolaryngol Head Neck Surg. 1999; 125(1) 21-27
- 98 Enjolras O, Brevière G M, Roger G et al.. Vincristine treatment for function- and life-threatening infantile hemangioma. Arch Pediatr. 2004; 11(2) 99-107
- 99 Perez J, Pardo J, Gomez C. Vincristine–an effective treatment of corticoid-resistant life-threatening infantile hemangiomas. Acta Oncol. 2002; 41(2) 197-199
- 100 Fawcett S L, Grant I, Hall P N, Kelsall A W, Nicholson J C. Vincristine as a treatment for a large haemangioma threatening vital functions. Br J Plast Surg. 2004; 57(2) 168-171
- 101 David L R, Malek M M, Argenta L C. Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: a review of 78 patients. Br J Plast Surg. 2003; 56(4) 317-327
- 102 Gupta G, Bilsland D. A prospective study of the impact of laser treatment on vascular lesions. Br J Dermatol. 2000; 143(2) 356-359
- 103 Poetke M, Philipp C, Berlien H. Flashlamp-pumped pulsed dye laser for hemangiomas in infancy: treatment of superficial vs mixed hemangiomas. Arch Dermatol. 2000; 136(5) 628-632
- 104 Waner M, Suen J, Dinehart S, Mallory S. Laser photocoagulation of superficial proliferating hemangiomas. J Dermatol Surg Oncol. 1994; 20(1) 43-46
- 105 Batta K, Goodyear H, Moss C et al.. Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis. Lancet. 2002; 360(9332) 521-527
- 106 Burrows P E, Rosenberg H, Chuang H. Diffuse hepatic hemangiomas: percutaneous transcatheter embolization with detachable silicone balloons. Radiology. 1985; 156(1) 85-88
- 107 Johnson D H, Vinson A M, Wirth F H et al.. Management of hepatic hemangioendotheliomas of infancy by transarterial embolization: a report of two cases. Pediatrics. 1984; 73(4) 546-549
- 108 Warmann S, Bertram H, Kardorff R et al.. Interventional treatment of infantile hepatic hemangioendothelioma. J Pediatr Surg. 2003; 38(8) 1177-1181
- 109 Holcomb 3rd G W, O'Neill Jr J A, Mahboubi S, Bishop H C. Experience with hepatic hemangioendothelioma in infancy and childhood. J Pediatr Surg. 1988; 23(7) 661-666
- 110 Stanley P, Grinnell V, Stanton R, Williams K, Shore N. Therapeutic embolization of infantile hepatic hemangioma with polyvinyl alcohol. AJR Am J Roentgenol. 1983; 141(5) 1047-1051
- 111 Jianhong L, Xianliang H, Xuewu J. Transcatheter arterial embolization in the treatment of extensive maxillofacial hemangioma in children. World J Surg. 2005; 29(12) 1550-1556
- 112 Andronikou S, Mandelstam S, Fasulakis S. MRI and preoperative embolization of a nasal cavity haemangioma in a child. Australas Radiol. 2003; 47(4) 386-388
- 113 Konior R J, Holinger L D, Russell E J. Superselective embolization of laryngeal hemangioma. Laryngoscope. 1988; 98(8 Pt 1) 830-834
- 114 Burrows P E, Lasjaunias P, Ter Brugge K, Flodmark O. Urgent and emergent embolization of lesions of the head and neck in children: indications and results. Pediatrics. 1987; 80(3) 386-394
- 115 Kaneko R, Tohnai I, Ueda M et al.. Curative treatment of central hemangioma in the mandible by direct puncture and embolisation with n-butyl-cyanoacrylate (NBCA). Oral Oncol. 2001; 37(7) 605-608
- 116 O'Donovan J C, Donaldson J S, Morello F P et al.. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. AJR Am J Roentgenol. 1997; 169(3) 723-729
- 117 Hayashi N, Masumoto T, Okubo T et al.. Hemangiomas in the face and extremities: MR-guided sclerotherapy–optimization with monitoring of signal intensity changes in vivo. Radiology. 2003; 226(2) 567-572
- 118 Winter H, Dräger E, Sterry W. Sclerotherapy for treatment of hemangiomas. Dermatol Surg. 2000; 26(2) 105-108
- 119 Zukerberg L R, Nickoloff B J, Weiss S W. Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol. 1993; 17(4) 321-328
- 120 Lyons L L, North P E, Mac-Moune Lai F et al.. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol. 2004; 28(5) 559-568
- 121 Enjolras O, Mulliken J, Wassef M et al.. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol. 2000; 42(2 Pt 1) 225-235
- 122 Gruman A, Liang M, Mulliken J et al.. Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. J Am Acad Dermatol. 2005; 52(4) 616-622
- 123 Hauer J, Graubner U, Konstantopoulos N et al.. Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach-Merritt phenomenon using four-drug regimen. Pediatr Blood Cancer. 2007; 49(6) 852-854
- 124 Harper L, Michel J, Enjolras O et al.. Successful management of a retroperitoneal kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon using alpha-interferon. Eur J Pediatr Surg. 2006; 16(5) 369-372
- 125 Haisley-Royster C, Enjolras O, Frieden I et al.. Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol. 2002; 24(6) 459-462
Sandeep VaidyaM.D.
Assistant Professor, Department of Radiology, University of Washington
1959 NE Pacific Street, Box #357115, Seattle, WA 98195
Email: svaidya@u.washington.edu